Darlene Deptula-Hicks

Darlene Deptula-Hicks is a seasoned financial professional with extensive experience in the biotechnology and therapeutics sectors. Currently serving as a Senior Strategic Financial Advisor at Grey Wolf Therapeutics and a Board Member at Avacta, Departmentula-Hicks also holds Board Member and Audit Committee Chair positions at Aerami Therapeutics and Abcuro, Inc. Previously, Departmentula-Hicks acted as Chief Financial Officer at F-star Therapeutics and T2 Biosystems, and held key roles at Giner Life Sciences and Pieris Pharmaceuticals. Educational background includes an MBA from Rivier University and a BS in Accounting from Southern New Hampshire University, complemented by executive training from The Tuck School of Business at Dartmouth.